Nasdaq-listed Cryoport, a temperature-controlled supply chain solutions company for the life sciences industry, has acquired France-based Cell&Co BioServices for €6.2m (US$6.72m), consisting of an upfront consideration of €3.6m in cash…
Nasdaq-listed Cryoport, a temperature-controlled supply chain solutions company for the life sciences industry, has acquired France-based Cell&Co BioServices for €6.2m (US$6.72m), consisting of an upfront consideration of €3.6m in cash…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


